Interstitial fluid pressure and associated lymph node metastasis revealed in tumors by dynamic contrast-enhanced MRI

Cancer Research

Volumn 72, Issue 19, 2012, Pages 4899-4908

  Hompland, Tord ^a   Ellingsen, Christine ^a   Øvrebø, Kirsti Marie ^a   Rofstad, Einar K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GADOLINIUM PENTETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; DISEASE MODEL; DYNAMIC CONTRAST ENHANCED NUCLEAR MAGNETIC RESONANCE IMAGING; FEMALE; FLOW RATE; FLUID FLOW; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MELANOMA; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPH NODE; PRIMARY TUMOR; PRIORITY JOURNAL; TISSUE PRESSURE; TUMOR XENOGRAFT; UTERINE CERVIX CANCER;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; EXTRACELLULAR FLUID; FEMALE; GADOLINIUM DTPA; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; PRESSURE; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

EID: 84867126737     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-0903     Document Type: Article

References (45)

1. Lunt SJ, Fyles A, Hill RP, Milosevic M. Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis. Future Oncol 2008;4:793-802.
2. Heldin CH, Rubin K, Pietras K, Östman A. High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer 2004;4:806-13. (Pubitemid 39331152)
3. Jain RK. Delivery of molecular medicine to solid tumors. Science 1996;271:1079-80. (Pubitemid 26075221)
4. Boucher Y, Jain RK. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 1992;52:5110-4.
5. Boucher Y, Baxter LT, Jain RK. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 1990;50:4478-84. (Pubitemid 20230379)
6. Eikenes L, Bruland ∅S, Brekken C, de Lange Davies C. Collagenase increases the transcapillary gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts. Cancer Res 2004;64:4768-73. (Pubitemid 38930817)
7. Jain RK. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst 1989;81:570-6. (Pubitemid 19104487)
8. Rofstad EK, Gaustad JV, Brurberg KG, Mathiesen B, Galappathi K, Simonsen TG. Radiocurability is associated with interstitial fluid pressure in human tumor xenografts. Neoplasia 2009;11:1243-51.
9. Rofstad EK, Ruud EBM, Mathiesen B, Galappathi K. Associations between radiocurability and interstitial fluid pressure in human tumor xenografts without hypoxic tissue. Clin Cancer Res 2010;16:936-45.
10. Rofstad EK, Tunheim SH, Mathiesen B, Graff BA, Halsør EF, Nilsen K, et al. Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. Cancer Res 2002;62:661-4. (Pubitemid 34126937)
11. Ellingsen C, Hompland T, Mathiesen B, Rofstad EK. Microenvironment- associated lymph node metastasis of human cervical carcinoma xenografts. Acta Oncol 2012;51:465-72.
12. Milosevic M, Fyles A, Hedley D, Pintilie M, Levin W, Manchul L, et al. Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res 2001;61:6400-5. (Pubitemid 32783245)
13. Yeo SG, Kim JS, Cho MJ, Kim KH, Kim JS. Interstitial fluid pressure as a prognostic factor in cervical cancer following radiation therapy. Clin Cancer Res 2009;15:6201-7.
14. Fyles A, Milosevic M, Pintilie M, Syed A, Levin W, Manchul L, et al. Long-term performance of interstitial fluid pressure and hypoxia as prognostic factors in cervix cancer. Radiother Oncol 2006;80:132-7. (Pubitemid 44314013)
15. Hassid Y, Furman-Haran E, Margalit R, Eilam R, Degani H. Noninvasive magnetic resonance imaging of transport and interstitial fluid pressure in ectopic human lung tumors. Cancer Res 2006;66:4159-66.
16. Gulliksrud K, Brurberg KG, Rofstad EK. Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure. Radiother Oncol 2009;91:107-13.
17. Gulliksrud K, Galappathi K, Rofstad EK. Interstitial fluid pressure and vascularity of intradermal and intramuscular human tumor xenografts. Int J Radiat Oncol Biol Phys 2011;80:258-64.
18. Haider MA, Sitartchouk I, Roberts TPL, Fyles A, Hashmi AT, Milosevic M. Correlations between dynamic contrast-enhanced magnetic resonance imaging-derived measures of tumor microvasculature and interstitial fluid pressure in patients with cervical cancer. J Magn Reson Imaging 2007;25:153-9. (Pubitemid 46095210)
19. Liu LJ, Brown SL, Ewing JR, Schlesinger M. Phenomenological model of interstitial fluid pressure in a solid tumor. Phys Rev E Stat Nonlin Soft Matter Phys 2011;84 (2 Pt 1):021919.
20. Jain RK, Tong RT, Munn LL. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Res 2007;67:2729-35. (Pubitemid 46548961)
21. Shields JD, Fleury ME, Yong C, Tomei AA, Randolph GJ, Swartz MA. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 2007;11:526-38. (Pubitemid 46856909)
22. Ellingsen C, Natvig I, Gaustad JV, Gulliksrud K, Egeland TAM, Rofstad EK. Human cervical carcinoma xenograft models for studies of the physiological microenvironment of tumors. J Cancer Res Clin Oncol 2009;135:1177-84.
23. Rofstad EK, Mathiesen B. Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia. Neoplasia 2010;12:889-98.
24. Benjaminsen IC, Graff BA, Brurberg KG, Rofstad EK. Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: a preclinical study of human melanoma xenografts. Magn Reson Med 2004;52:269-76. (Pubitemid 39025270)
25. Egeland TAM, Gaustad JV, Vestvik IK, Benjaminsen IC, Mathiesen B, Rofstad EK. Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast-enhanced MRI. Magn Reson Med 2006;55:874-82.
26. Ozerdem U, Hargens AR. A simple method for measuring interstitial fluid pressure in cancer tissues. Microvasc Res 2005;70:116-20. (Pubitemid 41565417)
27. Rofstad EK, Galappathi K, Mathiesen B, Ruud EBM. Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis. Clin Cancer Res 2007;13:1971-8. (Pubitemid 46649862)
28. Rosset A, Spadola L, Ratib O. OsiriX: an open-source software for navigating in multidimensional DICOM images. J Digit Imaging 2004;17:205-16. (Pubitemid 40378992)
29. Rofstad EK, Halsør EF. Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8. Br J Cancer 2002;86:301-8. (Pubitemid 34185162)
30. Reddy ST, Berk DA, Jain RK, Swartz MA. A sensitive in vivo model for quantifying interstitial convective transport of injected macromolecules and nanoparticles. J Appl Physiol 2006;101:1162-9. (Pubitemid 44497560)
31. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995;147:9-18.
32. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996;32A:2474-84.
33. Hasan J, Byers R, Jayson GC. Intra-tumoural microvessel density in human solid tumours. Br J Cancer 2002;86:1566-77. (Pubitemid 34628110)
34. Kobayashi M, Kawashima H, Matsui O, Zen Y, Suzuki M, Inokuchi M, et al. Two different types of ring-like enhancement on dynamic MR imaging in breast cancer: correlation with the histopathologic findings. J Magn Reson Imaging 2008;28:1435-43.
35. Uematsu T, Kasami M, Nicholson BT. Rim-enhancing breast masses with smooth or spiculated margins on magnetic resonance imaging: histopathology and clinical significance. Jpn J Radiol 2011;29:609-14.
36. Tsuda K, Murakami T, Kurachi H, Ogawa H, Oi H, Miyake A, et al. MR imaging of cervical carcinoma: comparison among T2-weighted, dynamic, and postcontrast T1-weighted images with histopathological correlation. Abdom Imaging 1997;22:103-7. (Pubitemid 27030228)
37. Zhang BY, Chen H, Geng DY, Yin B, Li YX, Zhong P, et al. Computed tomography and magnetic resonance features of gliosarcoma: a study of 54 cases. J Comput Assist Tomogr 2011;35:667-73.
38. Yu JS, Rofsky NM. Hepatic metastases: perilesional enhancement on dynamic MRI. AJR Am J Roentgenol 2006;186:1051-8. (Pubitemid 46100207)
39. Gulliksrud K, Hompland T, Galappathi K, Rofstad EK. Assessment of tumor hypoxia and interstitial fluid pressure by gadomelitol-based dynamic contrast-enhanced magnetic resonance imaging. Radiother Oncol 2011;101:217-22.
40. Mescam M, Eliat PA, Fauvel C, de Certaines JD, Bezy-Wendling J. A physiologically based pharmacokinetic model of vascular-extravascular exchanges during liver carcinogenesis: application to MRI contrast agents. Contrast Media Mol Imaging 2007;2:215-28. (Pubitemid 351166058)
41. Swabb EA, Wei J, Gullino PM. Diffusion and convection in normal and neoplastic tissues. Cancer Res 1974;34:2814-22.
42. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987;47:3039-51. (Pubitemid 17082621)
43. Rutkowski JM, Swartz MA. A driving force for change: interstitial flow as a morphoregulator. Trends Cell Biol 2007;17:44-50. (Pubitemid 46027589)
44. Mumprecht V, Detmar M. Lymphangiogenesis and cancer metastasis. J Cell Mol Med 2009;13:1405-16.
45. Swartz MA, Lund AW. Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nature Rev Cancer 2012;12:210-9.